Gossamer Bio
ID: 5332110Gossamer Bio is a clinical-stage biopharmaceutical public company developing products and therapies in the areas of immunology, inflammation, fibrosis and oncology.
2
Funding Rounds
$330.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Fa**** Ha***** | - | - | linkedin twitter |
| Sh**** Gu****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Fa**** Ha***** | - | - | linkedin twitter |
| Re**** Ga*** | - | - | |
| Th**** Da**** | - | - | - |
| Jo** Qu**** |
|
- | - |
| Sa**** Mi****** | - | - | |
| Ru**** Co* | - | - |
Funding
Funding series
Funding Series Analysis
The company Gossamer Bio has raised a total of $330m in funding over 2 rounds.
Key Insights:
- Gossamer Bio Series B round, July 2018: $230m
- Gossamer Bio Series A round, January 2017: $100m
Industries
Gossamer Bio is active in the following industries: